An interventional study of Cognitive Behavioral Therapy for Chronic Pain and Health and Wellness in Chronic Pain, Schizophrenia and Psychotic Disorders, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment
Ciesinski NK, Coakley GN, Nguyen RL, Loecher AK, Harvey KP, Travaglini LE. Affect, Coping, and Self-Harm Among Veterans With Comorbid Serious Mental Illness an…PubMed 41535739 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Chronic Pain by VA Office of Research and Development — 14 open to participants now, 15 under way, none of them phase 3. Chronic Pain · VA Office of Research and Development.
Among the 57 studies in Chronic Pain by VA Office of Research and Development, this one is the 35th largest by enrollment of the 53 interventional ones that give a count, is one of 8 that started in 2021, is one of 44 with no phase, and was the 26th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →14 of the 57 studies in Chronic Pain by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18–99 · Healthy volunteers
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18–89
By country, each count listing its studies:
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 8 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 47 is below the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 126 across the 53 interventional studies, 209 across the 4 observational. Of the 40 that completed or were terminated, 37 (93%) have results posted.
This tab as a report to print or save as PDF → With an account.
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
6 of the studies in Chronic Pain by VA Office of Research and Development that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05925036VA Office of Research and DevelopmentNovel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis | 2026-12-31 |
| NCT05563792VA Office of Research and DevelopmentOptions for Pain Management Using Nonpharmacological Strategies | 2027-01-31 |
| NCT06058624VA Office of Research and DevelopmentAssessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain | 2027-05-01 |
| NCT05811312VA Office of Research and DevelopmentBrain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study | 2027-06-30 |
| NCT06587607VA Office of Research and DevelopmentVR Mindfulness Training for Veterans With SCI | 2027-06-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 57 studies in Chronic Pain by VA Office of Research and Development, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Chronic pain has a highly negative impact on Veterans, especially those with serious mental illness (SMI). Chronic pain leads to poorer mental health and physical functioning, and represents a critical obstacle to rehabilitation and recovery. Despite known high prevalence rates of chronic pain in SMI populations, there is little research to: a) evaluate nonpharmacological pain management strategies in this population, and b) examine directional relations between chronic pain and SMI symptoms. This study aims to address research and clinical gaps by: a) testing the feasibility and acceptability of Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) - a VA evidence-based psychotherapy for chronic pain - in Veterans with SMI, and b) better assessing the complex relation between chronic pain and psychiatric symptoms and their impact on functioning. Results from this study will inform us as to whether CBT-CP is feasible to implement, acceptable to Veterans with SMI, and worth examining in its standard or in an optimized form in a larger clinical trial.
This research study will address critical gaps in our understanding and management of chronic musculoskeletal pain in Veterans with serious mental illness (SMI), addressing the following aims:
Aim 1: Complete a pilot randomized controlled trial (RCT) with 45 Veterans with co-occurring SMI and chronic musculoskeletal pain to examine feasibility and acceptability of CBT-CP and preliminarily evaluate participant responses to intervention.
Aim 1a (Primary): Determine feasibility by demonstrating adequate rates of recruitment and completion of and fidelity to the CBT-CP intervention as well as quality and acceptability of chosen assessments.
Aim 1b (Primary): Determine acceptability by obtaining favorable ratings from satisfaction questionnaires and interviews.
Aim 1c (Exploratory): Preliminarily evaluate participant responses to intervention by exploring changes in functioning and quality of life among Veterans randomized to the CBT-CP condition (n=30).
Aim 2: Determine the feasibility of collecting EMA data to examine the temporal relationships among mental health symptoms, pain severity, and health-related functioning. Data will be collected at baseline from the 45 Veterans in the Aim 1 RCT.
Aim 2b (Primary): Determine feasibility of this approach through adherence to the EMA call schedule and overall response rates.
Aim 2a (Exploratory): Explore relationships among mental health symptoms, pain severity, and health-related functioning captured in real time.
Aim 3: Complete a well-specified process evaluation to explore how to optimize CBT-CP for use in Veterans with SMI and chronic musculoskeletal pain in future clinical trials. This evaluation will integrate qualitative data from 15 interviews with Veterans in the CBT-CP condition, CBT-CP interventionist notes, and quantitative data from Aims 1 and 2.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) will be conducted in accordance with the Cognitive Behavioral Therapy for Chronic Pain: Therapist Manual and the VA Evidence-Based Practice (EBP) roll-out training. CBT-CP consists of a 12-session protocol, including an initial assessment session (BL assessment; Session 1), 10 content-specific sessions (pain education, goal-setting, cognitive and behavioral skill building; Sessions 2-11), and a booster session scheduled approximately one month after the final CBT-CP session (Session 12). Participants randomized to the CBT-CP condition (n = 30) will complete one 60-minute individual session per week. Each CBT-CP session will be led by a trained study interventionist using a manualized curriculum, following a basic structure including review of previous session material, introduction of new information or skills, and discussion of how to implement learned material into a home action plan.
Behavioral: Cognitive Behavioral Therapy for Chronic Pain
Health \& Wellness was developed by VISN 5 MIRECC investigators and consists of psychoeducation on topics related to physical and emotional wellbeing. Its structure is similar to CBT-CP (10 weekly individual 60-minute sessions, no booster session). Each Health \& Wellness session will be led by a trained interventionist using a manualized curriculum that includes review of previous session material, introduction of new information, and discussion of a range of health-related topics (physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating) that do not include pain. Typical sessions include discussion of the impact of the topic on overall health and well-being, identifying benefits and challenges to improving or maintaining health in that area, and strategies to address challenges in that area.
Behavioral: Health and Wellness
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) will be conducted in accordance with the Cognitive Behavioral Therapy for Chronic Pain: Therapist Manual and the VA Evidence-Based Practice (EBP) roll-out training. CBT-CP consists of a 12-session protocol, including an initial assessment session (BL assessment; Session 1), 10 content-specific sessions (pain education, goal-setting, cognitive and behavioral skill building; Sessions 2-11), and a booster session scheduled approximately one month after the final CBT-CP session (Session 12). Participants randomized to the CBT-CP condition (n = 30) will complete one 60-minute individual session per week. Each CBT-CP session will be led by a trained study interventionist using a manualized curriculum, following a basic structure including review of previous session material, introduction of new information or skills, and discussion of how to implement learned material into a home action plan.
Also known as: CBT-CP
Health \& Wellness was developed by VISN 5 MIRECC investigators and consists of psychoeducation on topics related to physical and emotional wellbeing. Its structure is similar to CBT-CP (10 weekly individual 60-minute sessions, no booster session). Each Health \& Wellness session will be led by a trained interventionist using a manualized curriculum that includes review of previous session material, introduction of new information, and discussion of a range of health-related topics (physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating) that do not include pain. Typical sessions include discussion of the impact of the topic on overall health and well-being, identifying benefits and challenges to improving or maintaining health in that area, and strategies to address challenges in that area.
Also known as: H&W
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Retention and Adherence
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2a: retention and adherence rates.
Time frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Treatment Completion Rates
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2b: treatment completion rates.
Time frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Sessions Completed
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2c: mean number of sessions attended
Time frame: Data will be gathered from each participant through intervention completion, an average of 11 weeks
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) Feasibility: Mean Number of Home Practices Completed
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 4: mean number of home practice assignments completed.
Time frame: Data will be gathered from each CBT-CP participant through intervention completion, an average of 11 weeks
Participant Satisfaction Questionnaire (CSQ-8)
Participants completed a treatment satisfaction survey at mid-treatment (\~session 5) and post-treatment (\~session 11) that included the Client Satisfaction Questionnaire-8. The CSQ-8 contains eight Likert scale items that ask about quality of service received and if services have been helpful. Average scores on the CSQ-8 range from 1 (lowest) to 4 (highest), with higher average scores indicating greater satisfaction. This measure was used to assess CBT-CP acceptability via treatment satisfaction surveys (Aim 1b). For analyses, post-treatment CSQ (week 11) was used for treatment completers; mid-point CSQ (week 5) was used for individuals who did not complete a full course of treatment.
Time frame: Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
Service Satisfaction Scale (SSS-18)
Participants were invited to complete a treatment satisfaction survey at mid-treatment (\~session/week 5) and post-treatment (\~session/week 11) that included the Service Satisfaction Scale-18 (SSS-18).The SSS-18 has 18 items that assess practitioner manner and skill, perceived outcome, office procedures, and accessibility. An average score was calculated for each participant, ranging from 1 (lowest) to 5 (highest). This measure was used to assess CBT-CP acceptability along with the CSQ-8 (Aim 1b). For analyses, post-treatment SSS-18 (week 11) was used for treatment completers; mid-point SSS-18 (week 5) was used for individuals who did not complete a full course of treatment.
Time frame: Participants were invited to complete a treatment satisfaction survey at mid-treatment (~session/week 5) and post-treatment (~session/week 11), with overall assessment also reported
Ecological Momentary Assessment - Feasibility, Completed Surveys
The Ecological Momentary Assessment (EMA) survey included 18 questions about pain severity, pain-related functioning (impact on stress, mood, sleep, activity; DVPRS), and SMI symptoms (depression \[PHQ-2\], mania \[ISS-A\], psychosis \[BASIS-24\]) experienced over the past hour. Pain-related items were derived from validated measures (Defense and Veterans Pain Rating Scale, pain severity and supplemental items) rated on a 0 (no pain/pain interference) to 10 (worst pain/complete interference); the sleep item was only asked once per day. Items from validated mental health symptom measures were used, but response scales were modified to yes/no format (i.e., whether person experienced the symptom in the past hour). Participants received three (3) surveys per day via text message (link to REDCap survey) for seven (7) days (21 total surveys); the first survey was delivered between 8am-12pm, the second between 12pm-4pm, and the third between 4pm-8pm.
Time frame: One week, between consent and baseline assessment
West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment)
The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale (WHYMPI-INT), a 9-item scale, will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.
Time frame: Post-treatment (approximately 12 weeks post-randomization)
Pain Severity (Pain Numeric Rating Scale, PNRS) - Post-Treatment
The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants will be assessed following completion of the study intervention, an expected average of 11 weeks
Time frame: Post-treatment (approximately 12 weeks post-randomization)
Veterans RAND 36-item Health Survey (VR-36) (Post-Treatment)
The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.
Time frame: Post-treatment (approximately 12 weeks post-randomization)
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Post-Treatment
The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.
Time frame: Post-treatment (approximately 12 weeks post-randomization)
World Health Organization Quality of Life Scale (WHOQOL-BREF) - Post-Treatment
The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.
Time frame: Post-treatment (approximately 12 weeks post-randomization)
West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up)
The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.
Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)
Pain Severity (Pain Numeric Rating Scale, PNRS) - Follow-up
The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants were assessed 3-months after completion of the study intervention, an expected average of 24 weeks post-randomization.
Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)
Veterans RAND 36-item Health Survey (VR-36) (Follow-up)
The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.
Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) - Follow-up
The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.
Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)
World Health Organization Quality of Life Scale (WHOQOL-BREF) - Follow-up
The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.
Time frame: 3-Month Follow-up (approximately 24 weeks post-randomization)
Veterans within VA Maryland Health Care System (VAMHCS) were recruited for the study from March, 2021 through September, 2024 via posted study flyers, provider outreach (email, staffing meetings), and DART list/medical record screening. 248 Veterans were contacted based on initial eligibility criteria (chronic pain, serious mental illness, receiving outpatient care at VAMHCS), of which n=119 refused participation and n=69 did not meet full eligibility criteria. N=60 Veterans were eligible.
| Milestone | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Started | 26 | 13 |
| Completed post assessment | 17 | 9 |
| Completed 3-month follow-up assessment | 20 | 8 |
| Completed | 14 | 7 |
| Not completed | 12 | 6 |
| Withdrew: Lost to follow-up | 7 | 3 |
| Withdrew: Withdrawal by subject | 5 | 3 |
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2a: retention and adherence rates.
| Participants | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Engaged (attended first 3 sessions) | 26 | 11 |
| Not Engaged (did not attend first 3 sessions) | 0 | 2 |
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2b: treatment completion rates.
| Participants | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Completed Full Course of Treatment | 14 | 7 |
| Did Not Complete Treatment | 12 | 6 |
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 2c: mean number of sessions attended
| Mean Number of Sessions | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Mean Number of Sessions: Overall Sample | 9.2 ± 3.20 | 8.4 ± 3.98 |
| Mean Number of Sessions: Treatment Completers | 11.6 ± 0.82 | 11.4 ± 0.94 |
| Mean Number of Sessions: Treatment Non-Completers | 6.4 ± 2.55 | 5.0 ± 3.29 |
The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale (WHYMPI-INT), a 9-item scale, will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Post-Treatment) | 3.99 ± 1.23 | 4.11 ± 1.42 |
The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants will be assessed following completion of the study intervention, an expected average of 11 weeks
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Pain Severity (Pain Numeric Rating Scale, PNRS) - Post-Treatment | 4.81 ± 2.40 | 4.56 ± 2.12 |
The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| VR-36 Physical Composite Score (PCS) | 40.42 ± 8.43 | 37.44 ± 10.91 |
| VR-36 Mental Composite Score (MCS) | 41.46 ± 12.67 | 34.31 ± 11.14 |
The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| WHODAS Overall Score | 40.94 ± 31.75 | 53.13 ± 30.05 |
| WHODAS - Cognition | 6.75 ± 5.84 | 8.88 ± 6.40 |
| WHODAS - Mobility | 7.31 ± 4.47 | 7.88 ± 5.87 |
| WHODAS - Self-Care | 3.56 ± 4.73 | 4.88 ± 4.26 |
| WHODAS - Getting Along with Others | 4.88 ± 5.11 | 5.75 ± 4.80 |
| WHODAS - Participating in Society | 10.5 ± 8.12 | 13.75 ± 6.86 |
| WHODAS - Life Activities | 7.94 ± 8.17 | 12.00 ± 6.82 |
The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| WHOQOL-BREF Overall | 53.47 ± 30.26 | 51.39 ± 17.05 |
| WHOQOl-BREF - Physical Health | 53.17 ± 23.91 | 44.44 ± 24.03 |
| WHOQOL-BREF - Emotional Health | 63.80 ± 20.08 | 47.69 ± 22.74 |
| WHOQOL-BREF - Social Relations | 54.63 ± 29.18 | 50.93 ± 18.84 |
| WHOQOL-BREF - Environmental Health | 67.44 ± 24.51 | 68.52 ± 11.45 |
The West Haven Yale Multidimensional Pain Inventory (WHYMPI) is a 52-item questionnaire providing a comprehensive assessment of components of the chronic pain experience that are helpful for the cognitive-behavioral conceptualization of chronic pain conditions. Each item is rated on a 7-point scale. The interference subscale will be used in this study and measures the impact of pain on functioning (household chores, outdoor work, recreation activities, social activities). An average score is calculated that ranges from 0 (no interference) to 6 (extreme interference). The WHYMPI has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The WHYMPI is used as part of the CBT-CP assessment protocol.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| West Haven-Yale Multidimensional Pain Inventory (WHYMPI) - Interference (Follow-up) | 3.88 ± 1.19 | 3.38 ± 1.38 |
The Pain Numeric Rating Scale (PNRS) assesses pain severity over the past week based on a 0 (no pain) to 10 (worst pain imaginable) scale. Three items - average pain over the past week, worst pain over the past week, least pain over the past week - are averaged for an overall pain severity score. The PNRS has been used with a wide range of chronic pain populations and is sensitive to change following rehabilitative interventions. The PNRS is used as part of the CBT-CP assessment protocol. Participants were assessed 3-months after completion of the study intervention, an expected average of 24 weeks post-randomization.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Pain Severity (Pain Numeric Rating Scale, PNRS) - Follow-up | 6.33 ± 1.78 | 5.96 ± 1.97 |
To examine feasibility, engagement and participation in CBT-CP will be tracked across four key objectives: 1) evaluation of recruitment and suitability of eligibility criteria (# consented divided by # approached; # randomized divided by # consented); 2) retention and adherence rates based on the percent who engaged in treatment (% of randomized who attend first 3 sessions) and mean number of sessions attended and treatment dropout percentages (# who dropped out prior to completing treatment divided by # who engaged); 3) outreach efforts (mean number of reminders and outreach contacts made for each participant); and 4) the mean (and SD) number of completed CBT-CP homework assignments, assessed weekly by CBT-CP interventionists. The table below shows outcomes for objective 4: mean number of home practice assignments completed.
| Percentage of Assignments Completed | Cognitive Behavioral Therapy for Chronic Pain |
|---|---|
| Mean Percent of Completed Home Practice Assignments: Overall CBT-CP Sample | 73.82 ± 33.35 |
| Mean Number of Completed Home Practice Assignments: Treatment Completers | 85.17 ± 17.50 |
| Mean Number of Completed Home Practice Assignments: Treatment Non-Completers | 59.36 ± 43.14 |
Participants completed a treatment satisfaction survey at mid-treatment (\~session 5) and post-treatment (\~session 11) that included the Client Satisfaction Questionnaire-8. The CSQ-8 contains eight Likert scale items that ask about quality of service received and if services have been helpful. Average scores on the CSQ-8 range from 1 (lowest) to 4 (highest), with higher average scores indicating greater satisfaction. This measure was used to assess CBT-CP acceptability via treatment satisfaction surveys (Aim 1b). For analyses, post-treatment CSQ (week 11) was used for treatment completers; mid-point CSQ (week 5) was used for individuals who did not complete a full course of treatment.
| Average score | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Mid-point treatment satisfaction | 3.73 ± 0.41 | 3.73 ± 0.48 |
| Post-treatment treatment satisfaction | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Overall - latest timepoint | 3.88 ± 0.79 | 3.60 ± 0.48 |
Participants were invited to complete a treatment satisfaction survey at mid-treatment (\~session/week 5) and post-treatment (\~session/week 11) that included the Service Satisfaction Scale-18 (SSS-18).The SSS-18 has 18 items that assess practitioner manner and skill, perceived outcome, office procedures, and accessibility. An average score was calculated for each participant, ranging from 1 (lowest) to 5 (highest). This measure was used to assess CBT-CP acceptability along with the CSQ-8 (Aim 1b). For analyses, post-treatment SSS-18 (week 11) was used for treatment completers; mid-point SSS-18 (week 5) was used for individuals who did not complete a full course of treatment.
| Average score | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| Mid-treatment | 4.67 ± 0.45 | 4.88 ± 0.15 |
| Post-treatment | 4.90 ± 0.23 | 4.63 ± 0.31 |
| Overall - last completed timepoint | 4.81 ± 0.36 | 4.90 ± 0.34 |
The Veterans RAND 36-Item Health Survey (VR-36) is a 36-item questionnaire measuring health-related quality of life and 8 domains of health-related functioning (physical functioning, role limitations due to physical problems, role limitations due to emotional problems, bodily pain, general health perceptions, vitality, social functioning, and mental health). Items are scored on a 3- to 6-point scale and are summed to create each of the domain scores, ranging from 0 (worst health status) to 100 (best health status). The VR-36 demonstrated improved reliability, precision, and validity compared to the SF-36 and among persons with SMI.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| VR-36 Physical Composite Score (PCS) | 36.63 ± 10.27 | 26.81 ± 9.56 |
| VR-36 Mental Composite Score (MCS) | 42.86 ± 12.07 | 32.23 ± 12.04 |
The WHODAS 2.0 is a 36-item questionnaire assessing health and disability across physical diseases and mental health disorders in both clinical and non-clinical settings and populations. Items are scored on a 5-point scale ranging from 0 (no difficulty) to 4 (extreme difficulty/cannot do) and are summed to create total (ranging from 0 to 144) and domain scores: cognition (ranging from 0 to 28); mobility (ranging from 0 to 20); self-care (ranging from 0 to 16); getting along with people (ranging from 0 to 20); life activities (ranging from 0 to 32); and participating in society (ranging from 0 to 32). Higher scores for each domain indicate greater disability. Psychometric properties are excellent, with high internal consistency, test-retest reliability, a stable factor structure, good concurrent validity, and good sensitivity to change.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| WHODAS Overall Score | 47.83 ± 29.49 | 45.87 ± 22.61 |
| WHODAS - Cognition | 7.83 ± 5.47 | 7.75 ± 5.44 |
| WHODAS - Mobility | 8.72 ± 5.23 | 8.38 ± 4.72 |
| WHODAS - Self-Care | 3.67 ± 3.60 | 4.13 ± 4.39 |
| WHODAS - Getting Along with Others | 4.83 ± 3.91 | 3.88 ± 3.48 |
| WHODAS - Participating in Society | 11.94 ± 8.32 | 12.00 ± 5.24 |
| WHODAS - Life Activities | 10.83 ± 8.93 | 9.75 ± 5.06 |
The World Health Organization Quality of Life Scale (WHOQOL-BREF) is a 26-item questionnaire assessing four domains of quality of life: physical health, psychological well-being, quality of social relationships, and environmental quality. Items use different anchors but are rated on a scale from 1 to 5. Mean scores are calculated for each domain and then transformed to range from 0 (poorest quality of life) to 100 (best quality of life). Psychometric properties of the WHOQOL-BREF are excellent, with demonstrated high internal consistency, discriminant validity, and construct validity for general, mental health, and physical health populations. The WHOQOL-BREF is used as part of the CBT-CP assessment protocol.
| score on a scale | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness |
|---|---|---|
| WHOQOL-BREF Overall | 56.58 ± 30.72 | 43.75 ± 23.15 |
| WHOQOl-BREF - Physical Health | 50.60 ± 21.51 | 45.98 ± 19.23 |
| WHOQOL-BREF - Emotional Health | 69.91 ± 19.10 | 53.65 ± 21.64 |
| WHOQOL-BREF - Social Relations | 56.48 ± 29.82 | 56.25 ± 11.57 |
| WHOQOL-BREF - Environmental Health | 66.14 ± 24.81 | 72.22 ± 15.43 |
The Ecological Momentary Assessment (EMA) survey included 18 questions about pain severity, pain-related functioning (impact on stress, mood, sleep, activity; DVPRS), and SMI symptoms (depression \[PHQ-2\], mania \[ISS-A\], psychosis \[BASIS-24\]) experienced over the past hour. Pain-related items were derived from validated measures (Defense and Veterans Pain Rating Scale, pain severity and supplemental items) rated on a 0 (no pain/pain interference) to 10 (worst pain/complete interference); the sleep item was only asked once per day. Items from validated mental health symptom measures were used, but response scales were modified to yes/no format (i.e., whether person experienced the symptom in the past hour). Participants received three (3) surveys per day via text message (link to REDCap survey) for seven (7) days (21 total surveys); the first survey was delivered between 8am-12pm, the second between 12pm-4pm, and the third between 4pm-8pm.
| Completed Surveys | Full Study Sample |
|---|---|
| Ecological Momentary Assessment - Feasibility, Completed Surveys | 14.79 ± 5.95 |
Collected over From enrollment until the end of follow-up, an average of 7 months per participant.. Non-serious events are listed at a 3% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Cognitive Behavioral Therapy for Chronic Pain | 0/26 (0%) | 0/26 (0%) | 0/26 (0%) |
| Health and Wellness | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) |
| Age, Continuous(Years) | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness | Total |
|---|---|---|---|
| Mean | 59.54 ± 11.19 | 52.77 ± 9.93 | 56.83 ± 11.31 |
| Sex/Gender, Customized(Participants) | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness | Total |
|---|---|---|---|
| Sex/Gender — Male | 20 | 5 | 25 |
| Sex/Gender — Female | 5 | 8 | 13 |
| Sex/Gender — Other (non-binary) | 1 | 0 | 1 |
| Race (NIH/OMB)(Participants) | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness | Total |
|---|---|---|---|
| American Indian or Alaska Native | 2 | 0 | 2 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 11 | 8 | 19 |
| White | 9 | 4 | 13 |
| More than one race | 2 | 1 | 3 |
| Unknown or Not Reported | 2 | 0 | 2 |
| Ethnicity (NIH/OMB)(Participants) | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness | Total |
|---|---|---|---|
| Hispanic or Latino | 2 | 1 | 3 |
| Not Hispanic or Latino | 23 | 12 | 35 |
| Unknown or Not Reported | 1 | 0 | 1 |
| Serious Mental Illness (SMI) diagnosis, per medical record(Participants) | Cognitive Behavioral Therapy for Chronic Pain | Health and Wellness | Total |
|---|---|---|---|
| Bipolar Disorders | 14 | 10 | 24 |
| Schizophrenia Spectrum | 10 | 2 | 12 |
| MDD with Psychosis | 2 | 1 | 3 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Mar 2021 to primary completion in Jul 2025, 51 months.
Results were first posted in Oct 2026, 1 year 3 months after primary completion.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 51 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Ciesinski NK, Coakley GN, Nguyen RL, Loecher AK, Harvey KP, Travaglini LE. Affect, Coping, and Self-Harm Among Veterans With Comorbid Serious Mental Illness an…PubMed 41535739 ↗
Ciesinski NK, Coakley GN, Nguyen RL, Loecher AK, Harvey KP, Travaglini LE. Affect, Coping, and Self-Harm Among Veterans With Comorbid Serious Mental Illness an…PubMed 41535739 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →